ArticleBlood and lymphatic cancer : targets and therapy2025
Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2.
Jianhua Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.